drugset

drugset / Trial / NCT04895488

Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia

NCT04895488 ↗

Phase 2/3 Unknown 37 enrolled Andalusian Public Foundation for Health Research in Seville

RandomizedCrossoverOpen-labelTreatment

Summary

Clinical trial to assess the efficacy of Vortioxetine compared with treatment as usual in early schizophrenia.

Timeline

Start: 2022-01-20
Primary completion: 2024-12-20
Completion: 2025-12-20

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Vortioxetine	Unknown	20 mg	—

Indications